Our initial results showed that micromolar concentrations of vorinostat could lead to a major reduction in the level of BRCA1 and RAD51 and as expected vorinostat led to increased sensitivity of various cancer cell lines to ABT-888. The gene discussed is BRCA1; the disease is cancer.